Cargando…

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer

The CD1d reactive glycolipid, α-galactosylceramide (α-GalCer), potently activates T cell receptor-α type I invariant NKT cells that secondarily stimulate the proliferation and activation of other leukocytes, including NK cells. Here we report a rational approach to improving the antitumor activity o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smyth, Mark J., Wallace, Morgan E., Nutt, Stephen L., Yagita, Hideo, Godfrey, Dale I., Hayakawa, Yoshihiro
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364507/ https://www.ncbi.nlm.nih.gov/pubmed/15967825 http://dx.doi.org/10.1084/jem.20042280

Ejemplares similares

Correction
por: Smyth, Mark J., et al.
Publicado: (2005)

Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
por: Smyth, Mark J., et al.
Publicado: (2000)

Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells
por: Street, Shayna E.A., et al.
Publicado: (2004)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

Differential antitumor immunity mediated by NKT cell subsets in vivo
por: Crowe, Nadine Y., et al.
Publicado: (2005)

NKT Cell-TCR Expression Activates Conventional T Cells in Vivo, but Is Largely Dispensable for Mature NKT Cell Biology
por: Vahl, J. Christoph, et al.
Publicado: (2013)

New ways to turn on NKT cells
por: Godfrey, Dale Ian, et al.
Publicado: (2011)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

NK and NKT-Like Cells in Patients with Recurrent Furunculosis
por: Nowicka, Danuta, et al.
Publicado: (2017)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

A Natural Killer T (NKT) Cell Developmental Pathway Involving a Thymus-dependent NK1.1(−)CD4(+) CD1d-dependent Precursor Stage
por: Pellicci, Daniel G., et al.
Publicado: (2002)

IL-21 Modulates Activation of NKT Cells in Patients with Stage IV Malignant Melanoma
por: Coquet, Jonathan M, et al.
Publicado: (2013)

Advances in NKT cell Immunotherapy for Glioblastoma
por: Pyaram, Kalyani, et al.
Publicado: (2018)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

P12. Combination of radiotherapy and chemotherapy with dendritic cell immunotherapy in glioblastoma patients induces NK and NKT cell responses
por: Pellegatta, S, et al.
Publicado: (2014)

A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance
por: Terabe, Masaki, et al.
Publicado: (2005)

Activation of Invariant NKT Cells Exacerbates Experimental Visceral Leishmaniasis
por: Stanley, Amanda C., et al.
Publicado: (2008)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking
por: Eriksson Ström, Jonas, et al.
Publicado: (2018)

miR-150 regulates the development of NK and iNKT cells
por: Bezman, Natalie A., et al.
Publicado: (2011)

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies
por: Shimizu, Kanako, et al.
Publicado: (2020)

Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy
por: Schmidt, Dayane, et al.
Publicado: (2022)

The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead
por: Nelson, Adam, et al.
Publicado: (2021)

Augmentation of NKT and NK cell-mediated cytotoxicity by peptidoglycan monomer linked with zinc.
por: Mrakovcić-Sutić, Ines, et al.
Publicado: (2002)

Differential inhibitory and activating NK cell receptor levels and NK/NKT-like cell functionality in chronic and recovered stages of chikungunya
por: Thanapati, Subrat, et al.
Publicado: (2017)

Key features and homing properties of NK cells in the liver are shaped by activated iNKT cells
por: Trittel, Stephanie, et al.
Publicado: (2019)

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Pilones, Karsten A., et al.
Publicado: (2012)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
por: Wolf, Benjamin J., et al.
Publicado: (2018)

NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis
por: Sokhatska, Oksana, et al.
Publicado: (2019)

Increased Numbers of NK Cells, NKT-Like Cells, and NK Inhibitory Receptors in Peripheral Blood of Patients with Chronic Obstructive Pulmonary Disease
por: Tang, Ying, et al.
Publicado: (2013)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

NKT cell adjuvants in therapeutic vaccines against hematological cancers
por: Mattarollo, Stephen R., et al.
Publicado: (2013)

Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
por: Aoki, Takahiro, et al.
Publicado: (2023)

Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
por: Morandi, Fabio, et al.
Publicado: (2020)

Hepatocyte-specific NEMO deletion promotes NK/NKT cell– and TRAIL-dependent liver damage
por: Beraza, Naiara, et al.
Publicado: (2009)

The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease‐modifying therapies
por: Ahmadi, Alireza, et al.
Publicado: (2022)

TLR4 and NKT Cell Synergy in Immunotherapy against Visceral Leishmaniasis
por: Karmakar, Subir, et al.
Publicado: (2012)

Altered Development of NKT Cells, γδ T Cells, CD8 T Cells and NK Cells in a PLZF Deficient Patient
por: Eidson, Maggie, et al.
Publicado: (2011)

Antitumor Immunity Produced by the Liver Kupffer Cells, NK Cells, NKT Cells, and CD8(+) CD122(+) T Cells
por: Seki, Shuhji, et al.
Publicado: (2011)

Differential Requirement for the CD45 Splicing Regulator hnRNPLL for Accumulation of NKT and Conventional T Cells
por: Yabas, Mehmet, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nooliq2bu1ed8qg888iddthoea